LATTERELL PATRICK F

CIK 00012018863 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001201886

Recent Transactions

50 trades

Purchase
Evoke Pharma Inc$EVOK
Common Stock
2018-08-20$2.35/sh+23,256→ 96,897 total
Purchase
Evoke Pharma Inc$EVOK
Common Stock
2018-08-20$2.35/sh+11,628→ 48,449 total
Purchase
Evoke Pharma Inc$EVOK
Common Stock
2018-08-20$2.35/sh+465,116→ 1,937,983 total
Conversion
Evoke Pharma Inc$EVOK
Common Stock
2013-09-30+52,711→ 52,711 total
Conversion
Evoke Pharma Inc$EVOK
Series A Preferred Stock
2013-09-30−131,784→ 0 total
Conversion
Evoke Pharma Inc$EVOK
Common Stock
2013-09-30+26,356→ 26,356 total
Conversion
Evoke Pharma Inc$EVOK
Common Stock
2013-09-30+1,054,262→ 1,054,262 total
Conversion
Evoke Pharma Inc$EVOK
Series A Preferred Stock
2013-09-30−263,566→ 0 total
Conversion
Evoke Pharma Inc$EVOK
Series A Preferred Stock
2013-09-30−5,271,317→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
2013-07-23−74,142→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+30,599→ 30,599 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+17,324→ 32,623 total
Conversion
OncoMed Pharmaceuticals Inc
Series A Preferred Stock
2013-07-23−426,315→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B Preferred Stock
2013-07-23−279,135→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B Preferred Stock
2013-07-23−611,995→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B Preferred Stock
2013-07-23−15,299→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
2013-07-23−316,079→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+611,995→ 611,995 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+34,649→ 65,248 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+65,476→ 165,476 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+279,135→ 705,450 total
Purchase
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23$17.00/sh+33,834→ 1,055,363 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+692,994→ 1,304,989 total
Purchase
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23$17.00/sh+43,223→ 1,348,212 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+15,299→ 15,299 total
Purchase
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23$17.00/sh+1,080→ 33,703 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+74,142→ 239,618 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+316,079→ 1,021,529 total
Purchase
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23$17.00/sh+2,161→ 67,409 total
Conversion
OncoMed Pharmaceuticals Inc
Series A Preferred Stock
2013-07-23−100,000→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B Preferred Stock
2013-07-23−65,476→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B Preferred Stock
2013-07-23−30,599→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
2013-07-23−34,649→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+100,000→ 100,000 total
Purchase
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23$17.00/sh+7,937→ 247,555 total
Conversion
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
2013-07-23−692,994→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Series B-1 Preferred Stock
2013-07-23−17,324→ 0 total
Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2013-07-23+426,315→ 426,315 total
Conversion
XTENT INC
Series D Convertible Preferred Stock
2007-02-06−196,458→ 0 total
Conversion
XTENT INC
Common Stock
2007-02-06+9,822→ 9,822 total
Conversion
XTENT INC
Common Stock
2007-02-06+196,458→ 196,458 total
Conversion
XTENT INC
Series D Convertible Preferred Stock
2007-02-06−75,842→ 0 total
Conversion
XTENT INC
Series B Convertible Preferred Stock
2007-02-06−412,234→ 0 total
Conversion
XTENT INC
Series D Convertible Preferred Stock
2007-02-06−9,822→ 0 total
Conversion
XTENT INC
Series A Convertible Preferred Stock
2007-02-06−775,000→ 0 total
Conversion
XTENT INC
Series A Convertible Preferred Stock
2007-02-06−225,000→ 0 total
Conversion
XTENT INC
Series C Convertible Preferred Stock
2007-02-06−571,955→ 0 total
Conversion
XTENT INC
Series C Convertible Preferred Stock
2007-02-06−166,051→ 0 total
Conversion
XTENT INC
Common Stock
2007-02-06+4,911→ 4,911 total
Conversion
XTENT INC
Common Stock
2007-02-06+2,020,425→ 2,020,425 total

Companies

Recent Filings

Address

ONE EMBARCADERO CENTER SUITE 4050

SAN FRANCISCO, CA, 94111

View on SEC.gov